BI
AVDL

BVF Inc’s Avadel Pharmaceuticals AVDL Stock Holding History

BVF Inc’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-151,406
Closed -$931K – 27
2013
Q2 		$931K Buy
+151,406
New +$782K 0.18% 22

Other funds holding AVDL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BVF Inc's AVDL Position: Q3 2013 in Review

BVF Inc sold out of Avadel Pharmaceuticals (AVDL) in Q3 2013, closing a stake of 151,406 shares — an estimated $931K sold.

BVF Inc first reported a position in AVDL in Q2 2013 and held it in 1 quarter. The position peaked at $931K in Q2 2013. 33 funds tracked by Wall St. Rank hold AVDL as of Q3 2013.

  • BVF Inc reported no remaining Avadel Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • BVF Inc sold 151,406 Avadel Pharmaceuticals shares in Q3 2013, an estimated $931K.
  • BVF Inc first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • BVF Inc's Avadel Pharmaceuticals position peaked at $931K in Q2 2013.
  • 33 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2013.

Based on BVF Inc's 13F filing for Q3 2013, filed 14 Nov 2013.